Bevacizumab in neoadjuvant treatment of patients with liver metastases from colorectal carcinoma

Bevacizumab in neoadjuvant treatment of patients with liver metastases from colorectal carcinoma

Background: Liver metastases are the leading cause of death in patients with colorectal cancer. Despite advances in chemotherapy, surgical resection of hepatic metastases is still considered the only curative options. However, the majority of patients have inoperable disease at presentation. Per...

Full description

Bibliographic Details
Main Authors: Ilić Miroslav, Majdevac Ivan, Petrović Tomislav, Ivković-Kapicl Tatjana, Nikolić Ivan, Pavin Svetlana, Kukić Biljana, Bogdanović Bogdan
Format: Article
Language:English
Published: Institute of Oncology, Sremska Kamenica, Serbia 2010-01-01
Series:Archive of Oncology
Subjects:
Colorectal Neoplasms
Neoplasm Metastasis
Liver Neoplasms
Chemotherapy
Adjuvant
Antibodies
Monoclonal
Online Access:http://www.doiserbia.nb.rs/img/doi/0354-7310/2010/0354-73101003075N.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0354-7310/2010/0354-73101003075N.pdf

Similar Items